ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Dysregulation of Immune Cell Glycolysis and Oxidative Phosphorylation Correlates with Development of Pre-liver Transplant Immune Dysfunction and Post-transplant Mortality

G. Panayotova1, L. Jin1, A. Lemenze1, S. Simonishvili1, Y. Qin1, L. Minze2, G. Dikdan1, F. Paterno1, X. C. Li2, M. Ghobrial2, J. V. Guarrera1, K. E. Lunsford1

1Transplant Surgery, Rutgers NJMS, Newark, NJ, 2Transplant Surgery, Houston Methodist Hospital, Houston, TX

Meeting: 2021 American Transplant Congress

Abstract number: 657

Keywords: Gene expression, Immune deviation, Infection, Liver cirrhosis

Topic: Clinical Science » Biomarkers, Immune Assessment and Clinical Outcomes

Session Information

Session Name: Biomarkers, Immune Assessment and Clinical Outcomes

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Cirrhosis-related immune dysfunction contributes to early morbidity and mortality following liver transplant (LT). We have previously identified a pre-LT biomarker panel, the immune frailty index (IFI), which accurately stratifies patients at high risk for post-transplant morbidity and mortality due to immune dysfunction. Prior work shows that impaired immune cell differentiation is central to this process. Here, we evaluate the genetic mechanisms responsible for these immunophenotypic alterations.

*Methods: IFI was calculated from pre-transplant HCV viremia, Eotaxin, MMP3, and Fractalkine. Pts with low IFI (Score 0-2) have a 95.5% 1yr survival compared with 46.2% for high IFI (Score 3-4). IFI-high were matched 1:2 with IFI-low based on age, sex, and cause of liver disease and were compared to healthy controls (NHC). RNA-seq was performed on PBMCs (d-1) and gene expression was used for principal component analysis (PCA) and clustering.

*Results: Gene expression analysis was performed on 22 LT recipients (n=7 IFI-high, n=15 IFI-low) and 8 NHCs. Donor and recipient characteristics were similar between groups. IFI-high had more positive cultures within 1yr post-op (4 vs 1, p<0.01) and lower 2yr survival (56% vs 100%, p<0.01). PCA analysis demonstrated 4 patterns of gene expression (clusters 1, 2, 3, and 4) with IFI-high predominantly in cluster 3; NHCs grouped together (cluster 5), Figure 1. Four patients died during median follow up of two years, all within the IFI-high cohort. Among these, 3/4 (75%) died secondary to infection-related complications (i.e. immune dysfunction), all in cluster 3. Gene analysis revealed mitochondrial function and oxidative phosphorylation genes were comparatively upregulated and glycolysis was comparatively downregulated in this patient group.

*Conclusions: Pre-transplant immune dysfunction in LT recipients is associated with significant alterations in immune cell metabolic pathways, including oxidative phosphorylation and glycolysis. Such metabolic dysregulation is known to abrogate immune cell differentiation into functional effectors. These alteration may direct immune frailty and increase LT recipients’ susceptibility to complications and death. Further evaluation of these pathways may offer a potential novel target to interrupt pre-transplant immune dysfunction and improve LT outcomes.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Panayotova G, Jin L, Lemenze A, Simonishvili S, Qin Y, Minze L, Dikdan G, Paterno F, Li XC, Ghobrial M, Guarrera JV, Lunsford KE. Dysregulation of Immune Cell Glycolysis and Oxidative Phosphorylation Correlates with Development of Pre-liver Transplant Immune Dysfunction and Post-transplant Mortality [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/dysregulation-of-immune-cell-glycolysis-and-oxidative-phosphorylation-correlates-with-development-of-pre-liver-transplant-immune-dysfunction-and-post-transplant-mortality/. Accessed May 11, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences